126 related articles for article (PubMed ID: 10228564)
1. The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium.
Pawlikowski M; Meleń-Mucha G; Mucha S
Cell Mol Life Sci; 1999 Mar; 55(3):506-10. PubMed ID: 10228564
[TBL] [Abstract][Full Text] [Related]
2. Angiotensins II and IV stimulate the rat anterior pituitary cell proliferation independently of the AT1 receptor subtype.
Ptasinska-Wnuk D; Kunert-Radek J; Pawlikowski M
Neuro Endocrinol Lett; 2003 Dec; 24(6):397-400. PubMed ID: 15073563
[TBL] [Abstract][Full Text] [Related]
3. Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.
Pawlikowski M; Gruszka A; Mucha S; Melen-Mucha G
Endocr Regul; 2001 Sep; 35(3):139-42. PubMed ID: 11674842
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
Taylor K; Patten RD; Smith JJ; Aronovitz MJ; Wight J; Salomon RN; Konstam MA
J Cardiovasc Pharmacol; 1998 May; 31(5):654-60. PubMed ID: 9593063
[TBL] [Abstract][Full Text] [Related]
5. The involvement of angiotensins in the control of prostatic epithelial cell proliferation in the rat.
Pawlikowski M; Mełén-Mucha G; Mucha S
Folia Histochem Cytobiol; 2001; 39(4):341-3. PubMed ID: 11766770
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the renin-angiotensin system may alter the adrenocortical regeneration.
Zieleniewski W
Cytobios; 2001; 104(406):127-32. PubMed ID: 11258541
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
Dukacz SA; Kline RL
J Hypertens; 1999 Sep; 17(9):1345-52. PubMed ID: 10489114
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Magga J; Kalliovalkama J; Romppanen H; Vuolteenaho O; Pörsti I; Kähönen M; Tolvanen JP; Ruskoaho H
J Hypertens; 1999 Nov; 17(11):1543-52. PubMed ID: 10608466
[TBL] [Abstract][Full Text] [Related]
9. Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
Yee KM; Struthers AD
Br J Clin Pharmacol; 1998 Dec; 46(6):583-8. PubMed ID: 9862248
[TBL] [Abstract][Full Text] [Related]
10. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.
Guba M; Steinbauer M; Büchner M; Frölich D; Farkas S; Jauch KW; Anthuber M
Shock; 2000 Mar; 13(3):190-6. PubMed ID: 10718375
[TBL] [Abstract][Full Text] [Related]
12. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
14. New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Richter M; Skupin M; Grabs R; Schramm D; Richter H; Olbrich HG
J Heart Lung Transplant; 2000 Nov; 19(11):1047-55. PubMed ID: 11077221
[TBL] [Abstract][Full Text] [Related]
15. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Richer C; Bruneval P; Ménard J; Giudicelli JF
Hypertension; 1998 Feb; 31(2):692-8. PubMed ID: 9461242
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
[TBL] [Abstract][Full Text] [Related]
17. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
[TBL] [Abstract][Full Text] [Related]
18. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
19. Angiotensins II and IV modulate adrenocortical cell proliferation in ovariectomized rats.
Siejka A; Mełeń-Mucha G; Mucha SA; Pawlikowski M
J Physiol Pharmacol; 2006 Sep; 57(3):451-61. PubMed ID: 17033097
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes.
Mervaala E; Dehmel B; Gross V; Lippoldt A; Bohlender J; Milia AF; Ganten D; Luft FC
J Am Soc Nephrol; 1999 Aug; 10(8):1669-80. PubMed ID: 10446934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
